Improving Thinking in Everyday Life After Covid-19 at the US University
Photo by Annie Spratt
The University of Alabama at Birmingham is recruiting patients for the clinical trial of Improving Thinking in Everyday Life After Covid-19.
The purpose of this study is to evaluate a new form of cognitive rehabilitation therapy for improving your ability to think, particularly how rapidly you process information that you receive from your senses, e.g., sight, hearing, and smell. The study will also test how often and how well you carry out tasks that rely on thinking in your daily life. Patients will be randomly assigned to receive the new therapy soon or about six months later. In other words, the treatment schedule will be determined by chance. The new therapy involves intensive, repetitive cognitive exercises (up to 3.5hr/day for 10 consecutive weekdays) with rest periods interspersed as needed.
The population that are excluded from participation the patients with cognitive impairment due to a developmental disability, psychiatric disorder, or substance abuse.
There are a number of conditions that allow participation, such as:
- presence of cognitive impairment due to Covid-19 infection;
- mild-to-moderate general cognitive impairment as determined by a Montreal Cognitive Assessment (MOCA) score between 10-25;
- at least 3 months after positive status for Covid-19
and others.
The indicative completion of the clinical trial will be expected in November 2024.
The study will take place at the University of Alabama at Birmingham, United States.
The page dedicated to this clinical trial can be found here:
